论文部分内容阅读
目的探讨速效救心丸和复方丹参滴丸治疗冠心病心绞痛的成本-效果。方法选取中国人民解放军第九八医院2015年1月—2016年2月收治的冠心病心绞痛患者160例。按入院顺序将患者分为研究组与对照组,各80例。两组患者均采取常规治疗,研究组给予口服速效救心丸,对照组给予复方丹参滴丸治疗。比较两组患者临床疗效、治疗成本,并做成本-效果分析。结果研究组患者总有效率高于对照组(P<0.05),治疗成本低于对照组。研究组成本-效果比低于对照组。在假设药价下降15%的基础上,研究组成本-效果比低于对照组。结论速效救心丸治疗冠心病心绞痛的疗效优于复方丹参滴丸,且成本较低,经济性较优。
Objective To investigate the cost-effectiveness of “Suxiaixinxin” and “Fufang Danshen” pills in the treatment of angina pectoris. Methods 160 patients with angina pectoris of coronary heart disease admitted to the 98th Hospital of Chinese PLA from January 2015 to February 2016 were selected. The patients were divided into study group and control group according to the order of hospital admission, 80 cases each. The two groups of patients were treated routinely, the study group given oral effective heart saving pills, the control group given compound Danshen dripping pills. The clinical efficacy, treatment costs, and cost-effectiveness analysis were compared between the two groups. Results The total effective rate of study group was higher than that of control group (P <0.05), and the treatment cost was lower than that of control group. The cost-effectiveness group was lower than the control group. Based on a 15% reduction in drug prices, the cost-effectiveness ratio of the study group was lower than that of the control group. Conclusion Suxiao Jiuxin Pill is superior to Fufang Danshen Dripping Pills in treating coronary heart disease angina pectoris, and the cost is lower and the economy is better.